Show
Sort by
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
- Journal Article
- A1
- open access
Underdetection of interstitial lung disease in juvenile systemic sclerosis (jSSc)
-
Differences sustained between diffuse and limited forms of juvenile systemic sclerosis in expanded international cohort
-
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases : insights after the first 5 years of the ERN ReCONNET
-
Sjögren's syndrome and other rare and complex connective tissue diseases : an intriguing liaison
-
- Journal Article
- A1
- open access
Development of a new international antiphospholipid syndrome classification criteria phase I/II report : generation and reduction of candidate criteria
-
The impact of COVID-19 on rare and complex connective tissue diseases : the experience of ERN ReCONNET
-
Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
-
- Journal Article
- A1
- open access
Undifferentiated connective tissue disease : state of the art on clinical practice guidelines
-
- Journal Article
- A1
- open access
Ehlers-Danlos syndromes : state of the art on clinical practice guidelines
-
- Journal Article
- A1
- open access
Mixed connective tissue disease : state of the art on clinical practice guidelines
-
- Journal Article
- A1
- open access
Antiphospholipid syndrome : state of the art on clinical practice guidelines
-
- Journal Article
- A1
- open access
Systemic lupus erythematosus : state of the art on clinical practice guidelines
-
- Journal Article
- A1
- open access
Idiopathic inflammatory myopathies : state of the art on clinical practice guidelines